{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:25:20Z","timestamp":1721694320493},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,22]]},"DOI":"10.7759\/cureus.65084","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T10:32:59Z","timestamp":1721644379000},"source":"Crossref","is-referenced-by-count":0,"title":["Navigating the Challenges of Factor X Deficiency: A Case Study"],"prefix":"10.7759","author":[{"given":"Gaurav A","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harin M","family":"Bhavsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhulika L","family":"Mahashabde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1225763","article-title":"Factor X deficiency","volume":"35","author":"Menegatti M","year":"2009","unstructured":"Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost. 2009, 35:407-15. 10.1055\/s-0029-1225763","journal-title":"Semin Thromb Hemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2023.2265650","article-title":"Acquired factor X deficiency in a multiple myeloma without amyloidosis: a case report","volume":"78","author":"Coussee A","year":"2023","unstructured":"Coussee A, Alliet G, Hervent AS, Vynckier L, Emmerechts J, Van Hecke S, Persijn L. Acquired factor X deficiency in a multiple myeloma without amyloidosis: a case report. Acta Clin Belg. 2023, 78:524-8. 10.1080\/17843286.2023.2265650","journal-title":"Acta Clin Belg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.6.1885","article-title":"Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy","volume":"97","author":"Choufani EB","year":"2001","unstructured":"Choufani EB, Sanchorawala V, Ernst T, Quillen K, Skinner M, Wright DG, Seldin DC. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood. 2001, 97:1885-7. 10.1182\/blood.v97.6.1885","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01856.x","article-title":"Diagnosis and treatment of inherited factor X deficiency","volume":"14","author":"Brown DL","year":"2008","unstructured":"Brown DL, Kouides PA. Diagnosis and treatment of inherited factor X deficiency. Haemophilia. 2008, 14:1176-82. 10.1111\/j.1365-2516.2008.01856.x","journal-title":"Haemophilia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.663","article-title":"Treatment of rare factor deficiencies in 2016","volume":"2016","author":"Peyvandi F","year":"2016","unstructured":"Peyvandi F, Menegatti M. Treatment of rare factor deficiencies in 2016. Hematology Am Soc Hematol Educ Program. 2016, 2016:663-9. 10.1182\/asheducation-2016.1.663","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12893","article-title":"Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency","volume":"22","author":"Austin SK","year":"2016","unstructured":"Austin SK, Kavakli K, Norton M, Peyvandi F, Shapiro A. Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency. Haemophilia. 2016, 22:419-25. 10.1111\/hae.12893","journal-title":"Haemophilia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford AD","year":"2014","unstructured":"Mumford AD, Ackroyd S, Alikhan R, et al.. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014, 167:304-26. 10.1111\/bjh.13058","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02635.x","article-title":"Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran","volume":"18","author":"Karimi M","year":"2012","unstructured":"Karimi M, Vafafar A, Haghpanah S, et al.. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran. Haemophilia. 2012, 18:211-5. 10.1111\/j.1365-2516.2011.02635.x","journal-title":"Haemophilia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259238-navigating-the-challenges-of-factor-x-deficiency-a-case-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T10:33:20Z","timestamp":1721644400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259238-navigating-the-challenges-of-factor-x-deficiency-a-case-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.65084","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,22]]}}}